{
    "2018-12-28": [
        [
            {
                "time": "",
                "original_text": "4亿资金悄然流出 今日主力部队摒弃十类股",
                "features": {
                    "keywords": [
                        "资金流出",
                        "主力部队",
                        "十类股"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "全市场"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "original_text": "医药生物2019年投资策略：创新才是硬道理",
                "features": {
                    "keywords": [
                        "医药生物",
                        "投资策略",
                        "创新"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "月内机构密集调研267家公司 化工等四行业成焦点",
                "features": {
                    "keywords": [
                        "机构调研",
                        "化工",
                        "行业焦点"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "化工",
                        "其他行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业:控费改革进程中关注结构性投资机会",
                "features": {
                    "keywords": [
                        "医药生物",
                        "控费改革",
                        "结构性投资机会"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}